Risk Stratification Procedure for Thromboembolism Prophylaxis

• Status: Completed
• Trial end date: 2019-07-22
• Target enrollment: 0
• Participant gender: All

Summary

The main objective for this study is validation for the proposed risk stratification tool, by evaluating the clinical outcomes for its use post TKR Surgeries. For this objective, the design that is used is Randomized Trial.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ministry of Health, Saudi Arabia
• Collaborators: Prince Sultan Military College of Health Sciences; Universiti Sains Malaysia; University of Science Malaysia
• Treatments: Aspirin

Criteria

Inclusion Criteria:

1. Male or Female patients who are planned for elective TKR surgery (primary only).

2. Agreed to sign the Informed consent form (ICF).

3. Patients aged older than 18 years.

Exclusion Criteria:

1. Patients receiving anticoagulant for treatment.

2. Patients with a history of DVT or PE were excluded from the study due to the marked increase in the risk of recurrent VTE compared to the general risk of (7% vs. 0.1%); (Fahrni, 2015).

3. Patients with renal or hepatic failure, renal failure is defined as end-stage kidney disease (on dialysis); hepatic failure is defined as complete liver cirrhosis.

4. Pregnant woman.

5. Revision surgeries.